Insights

Our new LearningLab: On-Demand Hub offers a growing library of continuing legal education (CLE) and business-focused legal insights you can now access anytime, anywhere.

Join Foley & Lardner LLP and BRG for a webinar exploring the intersection of trade secret litigation, digital forensics, and artificial intelligence.

Foley partner Judy Waltz, chair of the Health Care Practice Group, is speaking in the California Society for Healthcare Attorneys’ upcoming Fall Seminar in the session “Medicare & Medicaid Administrative Enforcement: Emerging Trends.”

Companies that depend on cross-border sourcing accordingly should consider whether they have evaluated their supply chains under realistic tariff-shock scenarios.

Biotech has been the bright spot in a selective IPO market, and the reason is not indiscriminate risk appetite. Investors are discriminating aggressively, and biotech gives them something to discriminate on.

California voted on whether to tax wealth and said no. Prop 40 failed [52 to 48], and Prop 42 wrote the no into the constitution [51 to 49]. Washington changed hands [in both chambers]. The first result changes how my clients plan and the second changes who asks them questions, and that is as much politics as this letter will carry. The deal market did not pause. Marvell signed $115 billion in stock for Lumentum on Sunday night, the largest semiconductor deal on record, and behind it came a $17 billion strategic deal, a $15 billion take-private, a $9 billion sponsor exit, a $1 billion round at $40 billion, and the wind-down of a firm that sat across the table from me for twenty-five years.

This episode features Nicole Strydom, Deputy General Counsel and Assistant Corporate Secretary at C.H. Robinson. In this conversation, Nicole reflects on her unconventional path to law, including her career as a professional cellist before attending Hamline School of Law.

This episode features a conversation with Jared Pliner. Jared is an associate in Foley's Boston office and a member of the Commercial Litigation Practice Group.

This episode features a conversation with Roland Potts. Roland is a partner in Foley’s Miami Office, Chair of the firm’s International Arbitration Team, and a member of the Commercial Litigation Practice Group.

Companies that depend on cross-border sourcing accordingly should consider whether they have evaluated their supply chains under realistic tariff-shock scenarios.

This self-check is designed to help companies assess whether they have a functioning, risk-aligned antitrust and fair-competition compliance framework.

Biotech has been the bright spot in a selective IPO market, and the reason is not indiscriminate risk appetite. Investors are discriminating aggressively, and biotech gives them something to discriminate on.